Complete dosage information for 1cP-MiPLA — threshold, light, common, strong, and heavy dose ranges across 1 route of administration.
Full 1cP-MiPLA profileImportant Safety Notice
Dosage information is for harm reduction purposes only. Individual sensitivity varies greatly. Always start with the lowest effective dose and work your way up slowly. Never eyeball doses — use a milligram scale.
Overdose The LD50 of 1cP-MiPLA is unknown. Adverse psychological reactions are common especially at higher dosages. Some of these include anxiety, delusions, panic attacks and more rarely seizures. Medical attention is usually only needed if suspected of severe psychotic episodes or “fake acid” (such as 25i-NBOMe or DOB). Administration of benzodiazepines or antipsychotics can help to relieve the negative cognitive effects of 1cP-MiPLA. 1cP-MiPLA is currently a gray area compound within many parts of the world. This means that it is not known to be specifically illegal within most countries, but people may still be charged for its possession under certain circumstances such as under analog laws and with the intent to sell or consume. - **Austria:** 1cP-MiPLA is technically not illegal but it may fall in the NPSG (Neue-Psychoaktive-Substanzen-Gesetz Österreich) as an analogue of LSD. - **Germany:** 1cP-MiPLA is illegal in Germany as of July 2021. - **Switzerland:** 1cP-MiPLA can be considered a controlled substance as a defined derivative of Lysergic Acid under Verzeichnis E point 263. It is legal when used for scientific or industrial use. - **United States:** 1cP-MiPLA is unscheduled but can be considered to be an analogue of LSD, which would make it illegal to possess for human consumption under the Federal Analogue Act. - Responsible use - Research chemical - Psychedelics - MiPLA - 1cP-LSD - 1cP-AL-LAD - EiPLA - LSD - 1cP-MiPLA (Isomer Design)
A common oral dose of 1cP-MiPLA is 150–200 µg.
The threshold dose for 1cP-MiPLA via oral is approximately 50 µg.
1cP-MiPLA typically lasts 4–6 hours via oral.